Subfatin concentration decreases in acute coronary syndrome

Introduction: We investigated the association of serum subfatin concentration and acute myocardial infarction (AMI) in patients with ST-elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI). Materials and methods: In this study, patients who presented with chest pain (STEMI, NSTEMI, or non-...

Full description

Bibliographic Details
Main Authors: Cagri Goktekin, M. (Author), Ilhan, N. (Author), Yilmaz, M. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 02905nam a2200373Ia 4500
001 10.11613-BM.2022.020704
008 220510s2022 CNT 000 0 und d
020 |a 18467482 (ISSN) 
245 1 0 |a Subfatin concentration decreases in acute coronary syndrome 
260 0 |b NLM (Medline)  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.11613/BM.2022.020704 
520 3 |a Introduction: We investigated the association of serum subfatin concentration and acute myocardial infarction (AMI) in patients with ST-elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI). Materials and methods: In this study, patients who presented with chest pain (STEMI, NSTEMI, or non-cardiac chest pain) were included, i.e. 49 patients with non-cardiac chest pain (control) and 66 patients hospitalised with AMI. In the AMI group, 35 patients had NSTEMI and 31 had STEMI. Serum subfatin concentrations were determined via enzyme-linked immunosorbent assay (ELISA). Descriptive data on the patients and their comorbidities were recorded, and subfatin concentrations were analysed. Results: Subfatin concentrations were significantly different in the control, STEMI and NSTEMI groups (P = 0.002). In addition, subfatin concentrations were significantly lower in patients in the NSTEMI group than those in the control group (P < 0.001), but there was no significant difference between STEMI and the control group (P = 0.143). The receiver operating characteristic (ROC) analysis performed for differentiating the AMI and control groups found that subfatin had 64% sensitivity and 69% specificity, whereas troponin had 59% sensitivity and 95% specificity. In patients with AMI, the ROC analysis for differentiating NSTEMI from STEMI found that subfatin had 94% sensitivity and 41% specificity, while troponin had 65% sensitivity and 88% specificity. Conclusions: Subfatin concentrations were lower in patients without STEMI than in patients with STEMI. Subfatin concentration is associated with NSTEMI. Croatian Society of Medical Biochemistry and Laboratory Medicine. 
650 0 4 |a acute coronary syndrome 
650 0 4 |a Acute Coronary Syndrome 
650 0 4 |a acute myocardial infarction 
650 0 4 |a Chest Pain 
650 0 4 |a heart infarction 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a Myocardial Infarction 
650 0 4 |a non ST segment elevation myocardial infarction 
650 0 4 |a Non-ST Elevated Myocardial Infarction 
650 0 4 |a non-ST-elevation myocardial infarction (NSTEMI) 
650 0 4 |a ST Elevation Myocardial Infarction 
650 0 4 |a ST segment elevation myocardial infarction 
650 0 4 |a ST-elevation myocardial infarction (STEMI) 
650 0 4 |a subfatin 
650 0 4 |a thorax pain 
650 0 4 |a troponin 
650 0 4 |a Troponin 
700 1 |a Cagri Goktekin, M.  |e author 
700 1 |a Ilhan, N.  |e author 
700 1 |a Yilmaz, M.  |e author 
773 |t Biochemia medica